(Total Views: 51)
Posted On: 12/03/2024 3:05:01 PM
Post# of 37283
NanoViricides, Inc. (NYSE: $NNVC), a clinical-stage company specializing in innovative nanomaterials for antiviral therapy, is making significant strides in the regulatory development of its lead drug candidate, NV-387.
Read more: https://tinyurl.com/3htrdcr2
Read more: https://tinyurl.com/3htrdcr2
(0)
(0)Scroll down for more posts ▼
